Halozyme Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
04.12.25
/
50%
€53.66
Target price
04.12.26
€48.01
Performance (%)
16.10%
Price
09.01.26
€62.30
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr currently has a performance of 16.10%. This prediction currently runs until 04.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 3.833% | 3.833% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $56.00 price target on the stock.
Ratings data for HALO provided by MarketBeat